{"id":"placebo-of-acetyl-l-carnitine","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"A placebo of Acetyl-L-Carnitine contains no active ingredient and produces therapeutic effects only through placebo response mechanisms. Acetyl-L-Carnitine itself is an acetylated form of the amino acid L-carnitine that supports mitochondrial energy metabolism, but the placebo version is inert.","oneSentence":"This is a placebo formulation with no active pharmacological mechanism.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:36:13.680Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06126315","phase":"PHASE2, PHASE3","title":"Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS","status":"RECRUITING","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2025-03-26","conditions":"Amyotrophic Lateral Sclerosis","enrollment":246},{"nctId":"NCT06573229","phase":"NA","title":"LIver FRAilty Management IN Cirrhosis (LIFRAMIN)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-08-02","conditions":"Sarcopenia, Cirrhosis, Liver, Malnutrition; Protein","enrollment":30},{"nctId":"NCT05284487","phase":"NA","title":"Clinical Trial to Evaluate Safety and Efficacy of Jalosome® Soothing Gel.","status":"UNKNOWN","sponsor":"Welcare Industries SpA","startDate":"2023-03-27","conditions":"Radiation-induced Dermatitis","enrollment":57},{"nctId":"NCT05653895","phase":"NA","title":"Independent and Additive Effects Of Micronutrients With Metformin In Patients With PCOS","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2022-12-07","conditions":"PCOS","enrollment":120},{"nctId":"NCT04790188","phase":"NA","title":"Effect of a Nootropic on the Cognitive Performance in Young Adults","status":"COMPLETED","sponsor":"Universidad de Granada","startDate":"2021-04-01","conditions":"Cognitive Change","enrollment":25},{"nctId":"NCT01695317","phase":"PHASE4","title":"Effect of Acetyl-L-carnitine in Migraine","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2013-04","conditions":"Migraine","enrollment":72},{"nctId":"NCT02955706","phase":"PHASE4","title":"Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2016-04-01","conditions":"Alzheimer Disease","enrollment":265},{"nctId":"NCT04346862","phase":"PHASE4","title":"Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease","status":"UNKNOWN","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2016-01-26","conditions":"Mild Cognitive Impairment","enrollment":636},{"nctId":"NCT04113889","phase":"PHASE2","title":"Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2019-10-15","conditions":"PCOS","enrollment":147},{"nctId":"NCT04177667","phase":"NA","title":"Body Mass Index and Age Correlate With Antioxidant Supplementation Effects on Sperm Quality","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2014-12-01","conditions":"Male Infertility","enrollment":104},{"nctId":"NCT03965819","phase":"NA","title":"A Study to Investigate the Efficacy of Pain Bloc-R in Healthy Participants With Non-pathological Aches and Discomfort","status":"COMPLETED","sponsor":"LifeSeasons Inc.","startDate":"2019-05-30","conditions":"Healthy","enrollment":27},{"nctId":"NCT02835664","phase":"NA","title":"Nicotinamide Riboside and Metabolic Health","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2016-12","conditions":"Obesity, Insulin Resistance","enrollment":15},{"nctId":"NCT00592488","phase":"PHASE1, PHASE2","title":"Acetyl-L-Carnitine in the Treatment of Septic Shock","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2006-08","conditions":"Septic Shock","enrollment":13},{"nctId":"NCT02141035","phase":"PHASE2, PHASE3","title":"Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2015-09","conditions":"Carpal Tunnel Syndrome, Compression Neuropathy","enrollment":20},{"nctId":"NCT00775645","phase":"PHASE3","title":"S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2009-09","conditions":"Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue","enrollment":437},{"nctId":"NCT02598622","phase":"PHASE2","title":"A Pilot Study Investigating the Effects of Acetyl-L-Carnitine and Vincristine-Induced Neuropathy in Pediatric Patients With ALL","status":"TERMINATED","sponsor":"Indiana University","startDate":"2009-09","conditions":"Vincristine Induced Neuropathy","enrollment":8},{"nctId":"NCT02891512","phase":"NA","title":"Very Low Frequency Magnetic Fields Versus the Supplement \"Xinepa\" in the Treatment of the Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2015-07","conditions":"Carpal Tunnel Syndrome","enrollment":31},{"nctId":"NCT02072759","phase":"NA","title":"Acetylcarnitine and Metabolic Flexibility","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2014-03","conditions":"Glucose Intolerance","enrollment":24},{"nctId":"NCT00572741","phase":"NA","title":"Treating Oxidative Stress and the Metabolic Pathology of Autism","status":"COMPLETED","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2008-06","conditions":"Autistic Disorder","enrollment":39},{"nctId":"NCT01320527","phase":"PHASE2","title":"A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-08","conditions":"Alzheimer's Disease, Mild Cognitive Impairment","enrollment":135},{"nctId":"NCT01524861","phase":"PHASE4","title":"Sympathetic Heart Innervation in Patients With Tako-Tsubo Cardiomyopathy","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2011-12","conditions":"Apical Ballooning Syndrome, Nervous System Diseases, Sympathetic","enrollment":90},{"nctId":"NCT01379976","phase":"PHASE3","title":"Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer","status":"TERMINATED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2011-04","conditions":"Non Small Cell Lung Cancer","enrollment":107},{"nctId":"NCT01471652","phase":"PHASE2","title":"Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2012-03","conditions":"Chronic Fatigue Syndrome","enrollment":""},{"nctId":"NCT01492920","phase":"PHASE3","title":"Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy","status":"WITHDRAWN","sponsor":"Gynecologic Oncology Group","startDate":"2012-04","conditions":"Fatigue, Malignant Ovarian Mixed Epithelial Tumor, Neuropathy","enrollment":""},{"nctId":"NCT00751205","phase":"PHASE2","title":"Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-08","conditions":"Prostate Cancer, Ovarian Cancer","enrollment":150},{"nctId":"NCT01526564","phase":"PHASE3","title":"Clinical Study on Acetyl-L-Carnitine","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2008-08","conditions":"Peripheral Sensory Neuropathy","enrollment":239},{"nctId":"NCT01909557","phase":"PHASE3","title":"Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.","status":"COMPLETED","sponsor":"University of Catania","startDate":"2010-01","conditions":"Quality of Life, Daily Activity, Fatigue","enrollment":62},{"nctId":"NCT00984750","phase":"PHASE3","title":"Acetyl-L-Carnitine in Type 2 Diabetes","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2008-04","conditions":"Diabetes Type 2, Hypertension","enrollment":229},{"nctId":"NCT00555841","phase":"PHASE2","title":"Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue","status":"TERMINATED","sponsor":"Sigma-Tau Research, Inc.","startDate":"2007-03","conditions":"Breast Cancer","enrollment":27},{"nctId":"NCT00719706","phase":"PHASE2","title":"The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2008-08","conditions":"Bipolar Depression","enrollment":40},{"nctId":"NCT00903695","phase":"PHASE2","title":"MemoryXL Effects on Mild Cognitive Impairment Patients","status":"TERMINATED","sponsor":"University of Oklahoma","startDate":"2009-06","conditions":"Mild Cognitive Impairment","enrollment":10},{"nctId":"NCT01223729","phase":"NA","title":"Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy","status":"COMPLETED","sponsor":"University of Catania","startDate":"2002-04","conditions":"Minimal Hepatic Encephalopathy","enrollment":67},{"nctId":"NCT00225160","phase":"PHASE2","title":"ALCAR Prophylaxis Study","status":"UNKNOWN","sponsor":"Royal Free Hampstead NHS Trust","startDate":"2003-11","conditions":"HIV Infections, Distal Symmetric Polyneuropathy","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo of Nicetile"],"phase":"marketed","status":"active","brandName":"Placebo of Acetyl-L-Carnitine","genericName":"Placebo of Acetyl-L-Carnitine","companyName":"Dong-A ST Co., Ltd.","companyId":"dong-a-st-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}